Head-to-Head

AIM ImmunoTech Inc. vs. Halozyme Therapeutics, Inc.

AIM

AIM ImmunoTech Inc.

$0.12 +0.50%

VS HALO

Halozyme Therapeutics, Inc.

$93.09 +0.06%

AIM ImmunoTech Inc. and Halozyme Therapeutics, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

AIMHALO
Market Cap $4.79 million $10.61 billion

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

AIMHALO
Short Interest 0.24% 9.75%

AIM leads on 1 of 1 risk & sentiment factors.

Dig deeper: AIM overview, AIM financials, HALO overview, HALO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.